Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KouKuiQing lozenge
- Development stage
- Phase 3
- Lead developer
- Guizhou Bailing Group Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Buccal
01
Overview
KouKuiQing lozenge is a Traditional Chinese Medicine (TCM) herbal formulation developed by Guizhou Bailing Group Pharmaceutical for the treatment of recurrent aphthous stomatitis (canker sores). It is specifically indicated for patients presenting with the heart–spleen heat syndrome according to TCM principles. The drug is formulated as a lozenge for local application in the oral cavity to promote ulcer healing, reduce pain, and prevent recurrence. Clinical evaluation has focused on its efficacy in improving ulcer healing rates and reducing the time to recovery in adults with mild recurrent aphthous ulcers.
- Brand names
- KouKuiQing
- Other names
- KouKuiQing Hanpian口溃清含片
Beyond the preview
Go deeper on KouKuiQing lozenge.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KouKuiQing lozenge.